You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

lenalidomide

Showing 1151 - 1173 of 1,173
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumors Trial in Innsbruck (Lenalidomide, Cetuximab)

Unknown status
  • Solid Tumors
  • Innsbruck, Tyrol, Austria
    Medical University of Innsbruck, Department for Internal Medicin
Jul 19, 2010

Chronic Lymphocytic Leukemia, CLL, Untreated Trial in United States (Lenalidomide and Rituximab)

Unknown status
  • Chronic Lymphocytic Leukemia
  • +5 more
  • Lenalidomide and Rituximab
  • La Jolla, California
  • +4 more
Sep 8, 2010

Solid Tumor Trial in Cleveland (docetaxel, lenalidomide)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Cleveland, Ohio
    Ireland Cancer Center at University Hosptials Case Medical Cente
Jun 10, 2010

Biological Data With Potential Prognostic Relevance in

Unknown status
  • Myelodysplastic Syndrome
    • Coppito, L'Aquila, Italy
    • +13 more
    Feb 7, 2011

    Complex Regional Pain Syndrome, Type 1 Trial in Rochester (Lenalidamide)

    Completed
    • Complex Regional Pain Syndrome, Type 1
    • Rochester, Minnesota
      Mayo Clinic
    Mar 22, 2011

    Glioblastoma, Gliosarcoma, Malignant Gliomas Trial in Boston, Charlottesville (lenalidomide, Radiation)

    Completed
    • Glioblastoma
    • +2 more
    • lenalidomide
    • Radiation
    • Boston, Massachusetts
    • +3 more
    Mar 8, 2010

    Multiple Myeloma Trial in Spain (Velcade, Melphalan, Prednisone)

    Completed
    • Multiple Myeloma
    • Oviedo, Asturias, Spain
    • +18 more
    Jan 8, 2011

    Multiple Myeloma Trial in Canada, United States (lenalidomide, dexamethasone)

    Completed
    Has Results
    • Multiple Myeloma
    • Scottsdale, Arizona
    • +68 more
    Mar 10, 2010

    Multiple Myeloma Trial in Little Rock (CC-5013 (Revlimid™), bortezomib)

    Completed
    • Multiple Myeloma
    • Little Rock, Arkansas
      University of Arkansas for Medical Sciences/MIRT
    Jul 1, 2010

    Radiculopathy Trial in United States (Lenalidomide (CC-5013))

    Completed
    • Radiculopathy
    • Lenalidomide (CC-5013)
    • Phoenix, Arizona
    • +22 more
    Sep 22, 2009

    Diffuse Large B-cell Lymphoma Trial in Australia, Canada, United States (CC-5013 (lenalidomide), dexamethasone)

    Terminated
    Has Results
    • Diffuse Large B-cell Lymphoma
    • Glendale, Arizona
    • +23 more
    Aug 27, 2009

    Relapse, Refractory Multiple Myeloma Trial in Wuerzburg (Revlimid)

    Completed
    • Relapse
    • Refractory Multiple Myeloma
    • Wuerzburg, Bavaria, Germany
      Dept. of Internal Medicine II, University of Wuerzburg
    Aug 3, 2009

    Multiple Myeloma Trial in Little Rock (CC-5013)

    Completed
    • Multiple Myeloma
    • Little Rock, Arkansas
      Myeloma Institute University of Arkansas for Medical Sciences
    Sep 22, 2009

    Multiple Myeloma, Stem Cell Transplantation Trial (allogeneic hematopoietic SCT)

    Completed
    • Multiple Myeloma
    • Stem Cell Transplantation
    • allogeneic hematopoietic SCT
    • (no location specified)
    May 27, 2009

    Complex Regional Pain Syndrome (RSD) Trial in United States (Lenalidomide)

    Completed
    • Complex Regional Pain Syndrome (RSD)
    • Lenalidomide
    • La Jolla, California
    • +5 more
    Dec 28, 2007

    MDS Trial in France (LENALIDOMIDE)

    Unknown status
    • Myelodysplastic Syndromes
    • LENALIDOMIDE
    • Angers, France
    • +10 more
    Mar 9, 2007

    NSCLC Trial in United States (CC-5013)

    Completed
    • Non-Small Cell Lung Cancer
    • Birmingham, Alabama
    • +5 more
    Dec 19, 2006

    Multiple Myeloma Trial in Italy (Revlimid (CC-5013))

    Completed
    • Multiple Myeloma
    • Revlimid (CC-5013)
    • San Giovanni Rotondo, Foggia, Italy
    • +8 more
    Nov 29, 2006

    Ovarian Cancer Trial in United States (CC-5013, liposomal doxorubicin)

    Terminated
    • Ovarian Cancer
    • San Francisco, California
    • +4 more
    Apr 10, 2006

    Prostate Cancer Trial in United States (CC5013)

    Terminated
    • Prostate Cancer
    • Berkeley, California
    • +5 more
    Nov 22, 2005

    Pancreatic Cancer Trial in United States (CC-5013, gemcitabine)

    Terminated
    • Pancreatic Cancer
    • Metairie, Louisiana
    • +5 more
    Nov 2, 2005

    NSCLC Trial in United States (CC-5013, pemetrexed)

    Terminated
    • Non-Small Cell Lung Cancer
    • Orlando, Florida
    • +4 more
    Nov 2, 2005

    Melanoma, Tumor Metastasis Trial in Canada, United States (CC 5013)

    Completed
    • Melanoma
    • Neoplasm Metastasis
    • CC 5013
    • Tucson, Arizona
    • +30 more
    Jun 23, 2005